Hematologic Malignancies

Filter By:
12:25
Cutting-edge updates and expert perspectives on the diagnosis and management of hematologic malignancies, including multiple myeloma, chronic lymphocytic leukemia and related disorders, and Hodgkin's and non-Hodgkin's lymphomas were presented and discussed at the 10th European Congress on Hematologic Malignancies. Dr. Campos presents an overview of...
by:imedex | 96 views
03:33
Antibody-drug conjugates or ADCs represent an innovative therapeutic application that combines the unique properties of monoclonal antibodies (mAbs) with the potent cell killing activity of cytotoxic small molecule drugs. The key components of antibody-drug conjugates include a monoclonal antibody (mAbs), a stable linkers and a cytotoxic (anti...
by:ADCReview | 259 views
22:28
Dr. Raymond Comenzo discusses the case of a patient with high-risk smoldering myeloma; whether to watch and wait, or treat immediately? This webcast was filmed live at the "How I Manage Multiple Myeloma: Smoldering and Newly Diagnosed Disease" lunch symposium during "Lymphoma &...
by:imedex | 297 views
10:32
Dr. Tomer Mark discusses the case of a transplant-elig​ible patient with newly diagnosed myeloma; whether to recommend transplant, and if so, what induction regimen? This webcast was filmed live at the "How I Manage Multiple Myeloma: Smoldering and Newly Diagnosed Disease" lunch symposiu...
by:imedex | 228 views
18:29
Dr. Ruben Niesvizky discusses the case of an elderly patient with newly diagnosed myeloma, and how to balance treatment with quality of life. This webcast was filmed live at the "How I Manage Multiple Myeloma: Smoldering and Newly Diagnosed Disease" lunch symposium during "Lymphoma...
by:imedex | 185 views
15:53
Dr. Antonio Polumbo discusses the case of a multiple myeloma patient who has responded well to induction therapy; whether maintenance therapy should be recommended, and, if so, what strategy should be used. This webcast was filmed live at the "How I Manage Multiple Myeloma: Smoldering and Ne...
by:imedex | 190 views
18:35
Dr. Joesph Mikhael discusses the optimal usage of newly approved agents — carfilzomib and pomalidomide — in treating relapsed/refrac​tory myeloma. This webcast was filmed live at the "Exploring New Treatment Options for Relapsed/Refrac​tory Multiple Myeloma: A Case-Based Discussion"​; lunch...
by:imedex | 214 views
21:34
Dr. Kenneth C. Anderson discusses experimental agents for relapsed/refrac​tory myeloma, and places current trials in context. This webcast was filmed live at the "Exploring New Treatment Options for Relapsed/Refrac​tory Multiple Myeloma: A Case-Based Discussion"​; lunch symposium during &qu...
by:imedex | 179 views
17:40
Dr. Ruben Niesvizky discusses the potential use for novel and emerging agents in patients with newly diagnosed and/or smoldering myeloma This webcast was filmed live at the "Exploring New Treatment Options for Relapsed/Refrac​tory Multiple Myeloma: A Case-Based Discussion"​; lunch symposiu...
by:imedex | 144 views
20:29
Dr. James Berenson discusses two cases: 1) a myeloma patient who has relapsed after frontline therapy, and 2) a myeloma patient who is refractory to both bortezomib and lenalidomide. This webcast was filmed live at the "Exploring New Treatment Options for Relapsed/Refrac​tory Multiple Myeloma: A Case-Based Discussion"​; lunch symposium du...
by:imedex | 157 views
Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)